12 West Capital Management LP Bio Techne Corp Transaction History

12 West Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $14.9 Million - $20.6 Million	52,648 New	52,648 $15 Million
Q4 2019 Feb 14, 2020	SELL	$189.68 - $222.09 $67.6 Million - $79.1 Million	-356,212 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$136.09 - $200.44 $4.76 Million - $7.02 Million	35,000 Added 10.9%	356,212 $70.7 Million
Q4 2018 Feb 14, 2019	BUY	$132.75 - $203.8 $3.98 Million - $6.11 Million	30,000 Added 10.3%	321,212 $46.5 Million
Q3 2018 Nov 14, 2018	BUY	$147.44 - $204.11 $42.9 Million - $59.4 Million	291,212 New	291,212 $59.4 Million

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.94B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of 12 West Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on 12 West Capital Management LP with notifications on news.